Back to Authors

Gertz, Morie A.

https://orcid.org/0000-0002-3853-5196

A5012884078 | I1330342723

Mayo Clinic

Citations 999

Outcomes of Multiple Myeloma Patients Refractory to Standard Dose Vs Low Dose Lenalidomide

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9998-9999

10.1182/blood-2022-160368

Muscle and Fat Composition in Patients with Newly Diagnosed Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7141-7143

10.1182/blood-2022-163746

Immunoglobulin Heavy Chain Amyloidosis: Patient Characteristics and Outcomes

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8092-8093

10.1182/blood-2022-164617

Evidence Supporting Light Chain Cast Nephropathy As a Myeloma Defining Event

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10068-10070

10.1182/blood-2022-162754

Performance of Glomerular Filtration Rate Estimating Equations in Cancer Patients Evaluated for Chimeric Antigen Receptor T-Cell Therapy

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10942-10944

10.1182/blood-2022-164785

Survival Benefit of Birtamimab in Mayo Stage IV AL Amyloidosis in the Phase 3 VITAL Study Consistent after Adjustment for Key Baseline Variables

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1839-1840

10.1182/blood-2022-159801

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10017-10019

10.1182/blood-2022-167181

Outcomes of Allogeneic Stem Cell Transplant for Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7182-7184

10.1182/blood-2022-156078

Waldenstrom Macroglobulinemia and the Clinical Implications of Acquired Von Willebrand Syndrome

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9363-9365

10.1182/blood-2022-168232

Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2399-2401

10.1182/blood-2022-167187